The limitations of our study are the small sample size and the staging of CKD patients not being evaluated, so a further study should be done with larger sample size and by comparing all the study parameters of CKD patients based on the staging of the disease to look for the possibility of serum α-Klotho as a potential marker for CKD in the near future. Here, KL is linked to chronic kidney disease.